izpis_h1_title_alt

QAC resistance genes in ESBL-producing E. coli isolated from patients with lower respiratory tract infections in the Central Slovenia region—a 21-year survey
ID Hrovat, Katja (Avtor), ID Čremožnik Zupančič, Jerneja (Avtor), ID Seme, Katja (Avtor), ID Ambrožič, Jerneja (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (838,07 KB)
MD5: 4F7382D0A99C274B323A0093064A27AB
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2414-6366/8/5/273 Povezava se odpre v novem oknu

Izvleček
Biocidal products prevent the spread of pathogenic microorganisms, including extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC), which is one of the most alarming health problems worldwide. Quaternary ammonium compounds (QACs) are surface-active agents that interact with the cytoplasmic membrane and are widely used in hospitals and food processing environments. A collection of 577 ESBL-EC, isolated from lower respiratory tract (LRT) samples, was screened for QAC resistance genes oqxA; oqxB; qacE∆1; qacE; qacF/H/I; qacG; sugE (p); emrE; mdfA; sugE (c); ydgE; ydgF; and for class 1, 2, and 3 integrons. The prevalence of chromosome-encoded genes ranged from 77 to 100%, while the prevalence of QAC resistance genes encoded on mobile genetic elements (MGEs) was relatively low (0–0.9%), with the exception of qacE∆1 (54.6%). PCR screening detected the presence of class 1 integrons in 36.3% (n = 210) of isolates, which were positively correlated with qacE∆1. More correlations between QAC resistance genes, integrons, sequence type group ST131, and β-lactamase genes were presented. The results of our study confirm the presence of QAC resistance genes and also class 1 integrons commonly found in multidrug-resistant clinical isolates and highlight the potential role of QAC resistance genes in the selection of ESBL-producing E. coli in hospitals.

Jezik:Angleški jezik
Ključne besede:Escherichia coli, lower respiratory tract, extended-spectrum β-lactamases, resistance gene, QAC, lower respiratory tract samples
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:BF - Biotehniška fakulteta
MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2023
Št. strani:12 str.
Številčenje:Vol. 8, iss. 5, art. 273
PID:20.500.12556/RUL-153248 Povezava se odpre v novem oknu
UDK:579
ISSN pri članku:2414-6366
DOI:10.3390/tropicalmed8050273 Povezava se odpre v novem oknu
COBISS.SI-ID:152196611 Povezava se odpre v novem oknu
Datum objave v RUL:20.12.2023
Število ogledov:250
Število prenosov:20
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Tropical medicine and infectious disease
Skrajšan naslov:Trop. med. infect. dis.
Založnik:MDPI
ISSN:2414-6366
COBISS.SI-ID:526463769 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:Escherichia coli, izolati, spodnje dihalne poti, β-laktamaze, razširjeno delovanje, rezistenčni geni, QAC

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0198
Naslov:Molekularno-biološke raziskave mikroorganizmov

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Program financ.:Young researchers

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj